UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061672
Receipt number R000070568
Scientific Title Validation of Innovative Transcutaneous Assessment of fLuid status Using Intravenous fluid loading in healthy adults
Date of disclosure of the study information 2026/07/01
Last modified on 2026/05/24 11:29:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Validation of Innovative Transcutaneous Assessment of fLuid status Using Intravenous fluid loading in healthy adults

Acronym

VITAL-FLUID Study

Scientific Title

Validation of Innovative Transcutaneous Assessment of fLuid status Using Intravenous fluid loading in healthy adults

Scientific Title:Acronym

VITAL-FLUID Study

Region

Japan


Condition

Condition

N/A

Classification by specialty

Nursing Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to evaluate the validity of a newly developed transcutaneous body fluid measurement method in healthy adults.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Temporal changes in the body fluid index

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

A 1-L intravenous fluid loading test using normal saline and 5% glucose solution will be performed.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Adults aged 18 years or older
2.Individuals with no history of being diagnosed with arrhythmia during health checkups or medical examinations
3.Individuals who are able to participate in the study conducted over two separate sessions
4.Individuals who have provided written informed consent for participation in the study

Key exclusion criteria

1.History of cardiovascular disease
2.Presence of any disease that may affect the cardiovascular system
3.Current use of medications that may affect the cardiovascular system
4.History of vasovagal reactions during blood sampling
5.Inability to maintain a resting position during the study procedures
6.Individuals deemed unsuitable for participation in this study by the investigators

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Konosuke
Middle name
Last name Sasaki

Organization

Tohoku University Graduate School of Medicine

Division name

Division of cardiovascular surgery and development of oncology nursing

Zip code

9808575

Address

2-1, Seiryo-machi, Aoba-ku, Sendai

TEL

022-717-7928

Email

konosuke.sasaki.b6@tohoku.ac.jp


Public contact

Name of contact person

1st name Konosuke
Middle name
Last name Sasaki

Organization

Tohoku University Graduate School of Medicine

Division name

Division of cardiovascular surgery and development of oncology nursing

Zip code

981

Address

2-1, Seiryo-machi, Aoba-ku, Sendai

TEL

022-717-7928

Homepage URL


Email

konosuke.sasaki.b6@tohoku.ac.jp


Sponsor or person

Institute

Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency (JST)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee Tohoku University Hospital

Address

1-1, Seiryo-machi, Aoba-ku, Sendai

Tel

022-728-4105

Email

ec@rinri.hosp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 06 Month 30 Day

Date of IRB


Anticipated trial start date

2026 Year 07 Month 01 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 05 Month 24 Day

Last modified on

2026 Year 05 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070568